The global market for pharmaceuticals is expected to grow at an annual rate of 4.9% to $1.3 trillion by 2020. The U.S pharma market is expected to grow to $320 billion by 2020. The Japan market, the third largest pharmaceutical market, has a forecasted growth of 3% while the U.S has an expected growth rate of 5.6%. Key Players in the Industry Pharmaceutical drugs are subject to a large number of laws and regulations that deal with patenting, testing, safety, efficacy and marketing and affect the size and growth rates of the market. Together with the high R&D costs involved in creating new drug solutions, these can act as barriers to entry for small companies. The market for pharmaceuticals is growing persistently. According to a current market report by the QuintilesIMS Institute, expenses for drugs will amount to 1.5 trillion U.S. dollars globally in 2021. This equals an average annual growth rate of between four and seven percent in medication expenses or three percent in doses. Market research firm Evaluate Pharma, in its annual World Preview report, projects a global growth rate for the pharma industry of 6.3% CAGR through 2022, up from the 5% CAGR it predicted last year for the 2014-2020 period. Nevertheless, for investors, the “spectacular four-year bull run” of pharma and biotech valuations during 2011-2015 might be coming to an end, with uncertainties over Brexit and the US presidential election, in an atmosphere of rising skepticism over the worth of Major Pharmaceutical Preparations Industry 's pace of Net Income growth in 4 Q 2019 decelerated to 6.75 % year on year, below Major Pharmaceutical Preparations Industry average. Sequentially cumulative Net Income fell by -3.34 %. Within Healthcare sector 2 other industries have achieved higher Net Income growth. This statistic displays the projected pharmaceutical revenue growth rate in form of the CAGR (compound annual growth rate) between 2015 and 2018, by region. During this period, the projected growth rate for the industry is 2.7 percent for Latin America.
18 Sep 2016 Market research firm Evaluate Pharma, in its annual World Preview report, projects a global growth rate for the pharma industry of 6.3% CAGR
Population of Iran as a Middle Eastern country with its population growth rate of The average age of pharmaceutical companies in Iran is over half century old 20 Jan 2020 This represents a compound annual growth rate of 3 to 6 percent between 2019 and that time. Unsurprisingly, the pharmaceutical market in the 10 Nov 2019 According to data from the market research firm AIOCD AWACS, the Indian Pharmaceutical Market (IPM) growth rate slipped to 5.1 per cent to All the categories of this market present dynamic growth, reporting an average annual growth rate (CAGR) between 2014 and 2017 of 4.9% for generic drugs, 5.9
14 Jan 2019 To the pharmaceutical industry, though, the US remains, unavoidably The average growth rate for drug spending in pharmerging markets
13 Sep 2018 global pharmaceutical industry, which is set to grow at an annual rate of 5 per cent between the same period!. The market is. expected to grow The Indian pharmaceutical industry is expected to grow at a compound annual growth rate (CAGR) of 22.4 per cent to touch US$ 55 billion by 2020. Export The outsourced manufacturing sector should continue its growth at a clip of the projected annual growth rate of the overall pharmaceutical industry (5.5%). Projection of the use of pharmaceutical products in Mexico (millions of dollars). Source: INEGI (2015). AAGR.- average annual growth rate. 2020. 20,024. 2018.
This statistic displays the projected pharmaceutical revenue growth rate in form of the CAGR (compound annual growth rate) between 2015 and 2018, by region. During this period, the projected growth rate for the industry is 2.7 percent for Latin America.
Indian Pharmaceutical Industry. Latest update: December, 2019. Growth bio- industry and bioinformatics is expected grow at an average growth rate of around The Indian pharma industry has been growing at a compounded annual growth rate (CAGR) of more than 15% over the last five years and has significant growth 16 May 2018 High failure rates, the $2 billion average cost of developing a new drug, Most pharmaceutical industry growth now is coming instead from the
16 May 2018 High failure rates, the $2 billion average cost of developing a new drug, Most pharmaceutical industry growth now is coming instead from the
1 Jun 2019 Even at current rates of seven to eight percent CAGR, the industry's annual revenues can grow to about USD 80 to 90 billion by 2030. However
Industry Characteristics. The pharmaceutical industry amassed $174.1 billion revenue with $39.2 billion in profits (Oliver, 2017) with an annual growth rate of 3.6% between 2012 to 2017 (Oliver, 2017). The loss of patent exclusivity allowed competition with generic pharmaceutical manufacturers (Oliver, 2017). A recent analysis by QuintilesIMS projects that the global pharmaceutical industry will grow at a compound annual rate of 4% to 7% during the next five years, down from the nearly 9% growth level seen in 2014 and 2015. DCAT Value Chain Insights takes a look inside the numbers. Contribution of Pharma Industry in GDP. Following a Growth Rate of 5.8%, the Gross Domestic Product of Pakistan (GDP) was expanded 3.3% in June 2019 and 1% of Nominal GDP of US$ 283.3 billion – with Per Capita of US$ 1480.9 – by 650 companies contributed in Pakistan’s Pharmaceutical Industry.